|
Summary Information: Rafael Holdings Inc. Class B Common Stock NYSE:RFL |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Rafael Holdings is focused on development of novel cancer therapies. The Company is a significant investor in two clinical stage oncology companies, Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd. Through its wholly owned Barer Institute subsidiary, the Company is developing a pipeline of compounds focused on the regulation of cancer metabolism.
__The following are links to various summary and news pages for __Rafael Holdings Inc. Class B Common Stock [ RFL ]. __Note: Some Links might not have information for the company. |
|